Ko, B., Tao, K., Brennan, L., Rakhade, S., Chan, C. X., Moone, J.-Y., Zhu, R., Sher, A., Wang, S., Bracero, Y., Fullerton, B., McLellan, B., Geskin, L. J., & Saenger, Y. M. (2024). Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients. Melanoma Research, 34(2), 134–141. https://doi.org/10.1097/cmr.0000000000000945

Wu, S. P., Keshavjee, S. H., Yoon, S. S., & Kwon, S. (2023). Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity. JAMA Network Open, 6(12), e2349026. https://doi.org/10.1001/jamanetworkopen.2023.49026

Rosenbaum, E., Chugh, R., Ryan, C. W., Agulnik, M., Milhem, M. M., George, S., Jones, R. L., Chmielowski, B., Van Tine, B. A., Tawbi, H., Elias, A. D., Read, W. L., Budd, G. T., Qin, L.-X., Rodler, E. T., Hirman, J., Weiden, P., Bennett, C. M., Livingston, P. O., … Carvajal, R. D. (2022). A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery. European Journal of Cancer, 176, 155–163. https://doi.org/10.1016/j.ejca.2022.09.003

Carvajal, R. D., Nathan, P., Sacco, J. J., Orloff, M., Hernandez-Aya, L. F., Yang, J., Luke, J. J., Butler, M. O., Stanhope, S., Collins, L., McAlpine, C., Holland, C., Abdullah, S. E., & Sato, T. (2022). Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40(17), 1939–1948. https://doi.org/10.1200/jco.21.01805

Yuen, C. A., Hsu, J.-M., Van Besien, K., Reshef, R., Iwamoto, F. M., Haggiagi, A., Liechty, B., Zhang, C., Wesley, S. F., & Magge, R. (2022). Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience. Journal of Immunotherapy, 45(5), 254–262. https://doi.org/10.1097/cji.0000000000000416